Gene Therapy for Wilson Disease Evaluated by 64Cu PET/CT

NCT07159581 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2025-09-08

No results posted yet for this study

Summary

The primary objective of this study is to investigate the effect of gene therapy (UX704) on copper distribution and excretion in Wilson disease patients. The effect is investigated using 64Cu positron emission tomography scans combined with a CT scan.

Conditions

  • Wilson Disease

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-08
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07159581 on ClinicalTrials.gov